Literature DB >> 19702425

Postconcussive symptoms in OEF-OIF veterans: factor structure and impact of posttraumatic stress.

Jared F Benge1, Nicholas J Pastorek, G Matthew Thornton.   

Abstract

PURPOSE: Veterans with a history of mild traumatic brain injury (mTBI) are reporting postconcussive symptoms (PCSx) in addition to experiencing postdeployment physical and emotional comorbidities. The Veterans Health Administration has mandated specialized evaluation and treatment for veterans with a history of mTBI and has suggested widespread use of the Neurobehavioral Symptom Inventory (NSI) as a measure of PCSx. This study evaluated the NSI's factor structure and assessed the impact of posttraumatic stress (PTS) on the scale at the item and factor levels. RESEARCH
METHOD: Five hundred twenty-nine charts of returning veterans who screened positive for traumatic brain injury were reviewed, and 345 who met criteria for mTBI were included in the study.
RESULTS: Results of factor analysis on the NSI revealed a difficult-to-interpret factor structure that was inconsistent with the results of civilian studies. PTS explained 5%-38% of the variance in individual PCSx, and after controlling for this variance, the factor structure more closely paralleled findings from the civilian literature.
CONCLUSION: PTS is an important variable to account for when evaluating PCSx in veterans. Research and clinical implications for the measurement and interpretation of self-reported PCSx are discussed. (c) 2009 APA

Entities:  

Mesh:

Year:  2009        PMID: 19702425     DOI: 10.1037/a0016736

Source DB:  PubMed          Journal:  Rehabil Psychol        ISSN: 0090-5550


  8 in total

Review 1.  Self-report measures to identify post traumatic stress disorder and/or mild traumatic brain injury and associated symptoms in military veterans of Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF).

Authors:  Lisa M Betthauser; Nazanin Bahraini; Maxine H Krengel; Lisa A Brenner
Journal:  Neuropsychol Rev       Date:  2012-02-19       Impact factor: 7.444

2.  Factor analysis of persistent postconcussive symptoms within a military sample with blast exposure.

Authors:  Laura M Franke; Jenna N Czarnota; Jessica M Ketchum; William C Walker
Journal:  J Head Trauma Rehabil       Date:  2015 Jan-Feb       Impact factor: 2.710

3.  APOE-ε4 Genotype is Associated with Elevated Post-Concussion Symptoms in Military Veterans with a Remote History of Mild Traumatic Brain Injury.

Authors:  Victoria C Merritt; Kristina M Lapira; Alexandra L Clark; Scott F Sorg; Madeleine L Werhane; Amy J Jak; Mark W Bondi; Dawn M Schiehser; Lisa Delano-Wood
Journal:  Arch Clin Neuropsychol       Date:  2019-07-26       Impact factor: 2.813

4.  Evaluating the Contribution of EEG Power Profiles to Characterize and Discriminate Posttraumatic Stress Symptom Factors in a Combat-Exposed Population.

Authors:  Christina M Sheerin; Laura M Franke; Steven H Aggen; Ananda B Amstadter; William C Walker
Journal:  Clin EEG Neurosci       Date:  2018-04-03       Impact factor: 1.843

Review 5.  Managing behavioral health needs of veterans with traumatic brain injury (TBI) in primary care.

Authors:  Paul R King; Laura O Wray
Journal:  J Clin Psychol Med Settings       Date:  2012-12

Review 6.  Neuropsychological and neuroimaging findings in traumatic brain injury and post-traumatic stress disorder.

Authors:  Lisa A Brenner
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

7.  Veterans have greater variability in their perception of binocular alignment.

Authors:  Michael C Schubert; Yoav Gimmon; Jennifer Millar; Kelly J Brewer; Dale Roberts; Mark Shelhamer; Charles Rohde; Jorge M Serrador
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

8.  Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation (INVENT VPT) Trial: study protocol for a randomized controlled crossover trial.

Authors:  Ann-Margret Ervin; Michael C Schubert; Americo A Migliaccio; Jamie Perin; Hamadou Coulibaly; Jennifer L Millar; Dale Roberts; Mark Shelhamer; Daniel Gold; Stephanie Beauregard; Robin Pinto; Douglas Brungart; Bryan K Ward
Journal:  Trials       Date:  2021-12-11       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.